HealthQuill Drugs
The US Food and Drug Administration has cleared Amgen’s drug to treat adult patients in the extensive stages of small cell lung cancer (ES-SCLC) with disease progression on or after chemotherapy.
Drugs Health Pharma

USFDA gives nod to Amgen’s therapy for treating small cell lung cancer 

HQ Team May 17, 2024: The US Food and Drug Administration has cleared Amgen’s drug to treat adult patients in the extensive stages.

Read More
Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to a statement.
Drugs Health Pharma

Johnson & Johnson to buy Proteologix Inc., for $850 million in cash

HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to.

Read More
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to the WHO.
Drugs Health Pharma

Labcrop unveils new blood test to predict preeclampsia early in pregnant women

HQ Team May 16, 2024: Preeclampsia is a serious hypertensive complication of pregnancy that affects roughly 2% to 8% of pregnant women worldwide..

Read More
The World Health Organization has prequalified a dengue vaccine for children made by Japan’s Takeda Pharmaceutical Company — the third-largest drug firm in Asia.
Drugs Health Pharma

WHO prequalifies Japan-based Takeda’s dengue vaccine for children

HQ Team May 15, 2024: The World Health Organization has prequalified a dengue vaccine for children made by Japan’s Takeda Pharmaceutical Company —.

Read More
An 18-month-old baby girl, Opal Sandy, who was born deaf got back her hearing ability after gene therapy — the youngest child to receive such treatment.
Drugs Health Pharma

Deaf 18-month girl gets back hearing ability after gene therapy

HQ Team May 15, 2024: An 18-month-old baby girl, Opal Sandy, who was born deaf got back her hearing ability after gene therapy.

Read More
Families of patients with severe traumatic brain injury will have to think twice before plugging out the life support systems of their near ones as a study cited “poor neurologic prognosis” by physicians as the main reason for withdrawing the breathing aid.
Drugs Health Pharma

Jury out on when to unplug life-support for patients with brain injury

HQ Team May 14, 2024: Families of patients with severe traumatic brain injury will have to think twice before plugging out the life.

Read More
Factors like the patient’s character, carer’s personality and attitude towards the patient, relationship between the carer and patient, time spent together, and the severity of the illness impact the intensity of the caregiver burden.
Drugs Health Opinion Pharma

Opinion: Who will worry about caregivers for the mentally ill?

By Aparna S May 14, 2024: A caregiver is a person who takes care of and provides for another individual who cannot take.

Read More
BioNTech signs pact with Australia
Drugs Health Medical

Covid-19 vaccines increase life expectancy of heart patients, study

HQ Team May 13, 2024:  New research says Covid-19 vaccines given to people suffering from heart failure improve their chances of living longer.

Read More
The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer.
Drugs Medical Pharma

Merck discontinues trial for combo cancer drug for melanoma

HQ Team May 13, 2024: Merck has discontinued another cancer experimental immunotherapy treatment in patients with a severe form of melanoma due to.

Read More
Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance Minister Bruno Le Maire said, according to a publicly-funded television network, France 24.
Drugs Health Pharma

Pfizer, AstraZeneca to invest close to $1 billion in France to expand

HQ Team May 13, 2024: Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance.

Read More